Crossmark

Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea

Crossref DOI link: https://doi.org/10.1186/s12936-022-04103-y

Published Online: 2022-03-24

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mpina, Maxmillian https://orcid.org/0000-0002-9300-6430
Stabler, Thomas C.

Schindler, Tobias

Raso, Jose

Deal, Anna

Acuche Pupu, Ludmila

Nyakarungu, Elizabeth

del Carmen Ovono Davis, Maria

Urbano, Vicente

Mtoro, Ali

Hamad, Ali

Lopez, Maria Silvia A.

Pasialo, Beltran

Eyang, Marta Alene Owono

Rivas, Matilde Riloha

Falla, Carlos Cortes

García, Guillermo A.

Momo, Juan Carlos

Chuquiyauri, Raul

Saverino, Elizabeth

Preston Church, L. W.

Kim lee Sim, B.

Manguire, Bonifacio

Tanner, Marcel

Maas, Carl

Abdulla, Salim

Billingsley, Peter F.

Hoffman, Stephen L.

Jongo, Said

Richie, Thomas L.

Daubenberger, Claudia A.
License Information

Text and Data Mining valid from 2022-03-24

Version of Record valid from 2022-03-24
More Information

Article History

Received: 8 November 2021

Accepted: 23 February 2022

First Online: 24 March 2022

Declarations

:

: Ethics approval was obtained to conduct the malaria vaccine trial from the Comité Ética Nacional de Guinea Ecuatorial (CENGE) in Equatorial Guinea, Ifakara Health Institute (IHI) in Tanzania, Ethikkommission Nordwest- und Zentralschweiz (EKNZ) in Switzerland, and Prime IRB in the USA. Included in this approval was the use of participant biological samples for future use if informed consent was provided. No identifying information was accessible to laboratory staff and was not included in any database or analysis for this study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below